系统综述与荟萃分析:儿童和青少年炎症性肠病患者的焦虑与抑郁
该系统综述与荟萃分析检索1994至2017年多个数据库,纳入28项研究(N=8107,平均年龄14.3岁),评估6-18岁炎症性肠病患者焦虑和抑郁症状及障碍的患病率。焦虑症状合并患病率为16.4%(95%CI 6.8%-27.3%),焦虑障碍为4.2%(95%CI 3.6%-4.8%);抑郁症状为15.0%(95%CI 6.4%-24.8%),抑郁障碍为3.4%(95%CI 0%-9.3%)。作者结论认为症状合并患病率低于成人炎症性肠病,但因测量工具和截断值不一且障碍研究较少,结果需谨慎解读。
要点
- 儿童和青少年炎症性肠病患者焦虑症状合并患病率为16.4%(95%CI 6.8%-27.3%)。
- 抑郁症状合并患病率为15.0%(95%CI 6.4%-24.8%),低于成人炎症性肠病。
- 疾病活动比例较高的研究中抑郁症状患病率较高,疾病类型和性别未见影响。
核心结论
- 儿童和青少年炎症性肠病患者焦虑和抑郁症状的合并患病率低于成人炎症性肠病。
- 由于测量症状的工具和截断值不一且研究障碍的文献较少,结果应谨慎解读。
- 需要跨文化使用相同工具以更好地了解患病率。
研究设计与样本
- 系统综述与荟萃分析,检索Embase、Medline Ovid、Web of Science、Cochrane、PubMed、PsychInfo Ovid和Google scholar从1994年至2017年发表的研究。
- 纳入28项研究,总样本N=8107,平均年龄14.3岁,对象为6-18岁炎症性肠病患者。
- 采用逆方差异质性模型计算合并患病率,并用荟萃回归分析疾病类型、疾病活动和性别对患病率的影响。
主要发现
- 焦虑症状合并患病率为16.4%(95%CI 6.8%-27.3%),焦虑障碍合并患病率为4.2%(95%CI 3.6%-4.8%)。
- 抑郁症状合并患病率为15.0%(95%CI 6.4%-24.8%),抑郁障碍合并患病率为3.4%(95%CI 0%-9.3%)。
- 荟萃回归显示疾病类型和性别对上述患病率无影响,但疾病活动比例较高的研究中抑郁症状患病率较高。
关键数值与推荐
- 焦虑症状合并患病率16.4%(95%CI 6.8%-27.3%),焦虑障碍4.2%(95%CI 3.6%-4.8%)。
- 抑郁症状合并患病率15.0%(95%CI 6.4%-24.8%),抑郁障碍3.4%(95%CI 0%-9.3%)。
- 疾病活动比例较高的研究中抑郁症状患病率较高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 测量症状的工具和截断值不一。
- 研究障碍的文献较少。
- 结果应谨慎解读。
- 需要跨文化使用相同工具以更好地了解患病率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The co-existence of psychological problems and paediatric inflammatory bowel disease (IBD) is receiving increasing attention. Most studies investigated anxiety and depression, with prevalence rates varying from 0% to 50%. A systematic review is necessary to provide clear insight into the prevalence of anxiety and depression in paediatric IBD. AIM: To systematically evaluate available data on the prevalence of anxiety and depressive symptoms and disorders in paediatric IBD (aged 6-18 years). METHODS: Comprehensive searches were performed in Embase, Medline Ovid, Web of Science, Cochrane, PubMed, PsychInfo Ovid, and Google scholar for studies published from 1994 to 2017. Pooled prevalence rates were calculated using inverse variance heterogeneity models. Meta-regression was used to study if disease type, disease activity and gender influence prevalence. RESULTS: Twenty-eight studies (N = 8107, mean age: 14.3) were identified. Pooled prevalence estimates were 16.4% (95% confidence interval [CI] 6.8%-27.3%) for anxiety symptoms and 4.2% (95% CI 3.6%-4.8%) for anxiety disorders. Pooled prevalence estimates were 15.0% (95% CI 6.4%-24.8%) for depressive symptoms and 3.4% (95% CI 0%-9.3%) for depressive disorders. Meta-regression showed no influence of disease type or gender on these prevalence rates, but studies with a higher percentage of active disease had a higher rate of depressive symptoms. CONCLUSIONS: The described pooled prevalence of anxiety and depressive symptoms is lower than in adult IBD. However, due to varying instruments/cut-offs for measuring symptoms and few studies investigating disorders, the results should be interpreted with caution. Cross-cultural use of the same instruments is needed to gain better insight into prevalence rates.
引用
- Stapersma L, van den Brink G, Szigethy EM, et al. Systematic review with meta-analysis: anxiety and depression in children and adolescents with inflammatory bowel disease. Aliment Pharmacol Ther. 2018. PMID: 29984495. doi:10.1111/apt.14865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。